ストックスクリーナーアプリを入手
1.67
4.37%
0.07
アフターアワーズ：
1.65
-0.02
-1.20%
前日終値:
$1.60
開ける：
$1.64
24時間の取引高:
348.67K
Relative Volume:
0.77
時価総額：
$218.19M
収益：
-
当期純損益:
$-35.47M
株価収益率:
-2.9298
EPS:
-0.57
ネットキャッシュフロー:
$-124.27M
1週間 パフォーマンス:
-1.76%
1か月 パフォーマンス:
-4.30%
6か月 パフォーマンス:
-24.77%
1年 パフォーマンス:
+19.29%
1日の値動き範囲:
$1.6178
$1.73
1週間の範囲:
$1.565
$1.82
52週間の値動き範囲:
$1.18
$4.44
Prokidney Corp Stock (PROK) Company Profile
PROK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
1.67 | 218.19M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-30 | 開始されました | JP Morgan | Neutral |
| 2024-09-10 | 開始されました | Guggenheim | Buy |
| 2024-03-07 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-01-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-07-25 | 開始されました | BTIG Research | Buy |
| 2022-12-21 | 開始されました | Jefferies | Buy |
| 2022-11-10 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-10-18 | 開始されました | UBS | Buy |
| 2022-10-14 | 開始されました | Citigroup | Buy |
| 2022-09-23 | 開始されました | BofA Securities | Buy |
| 2022-09-02 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Prokidney Corp (PROK) 最新ニュース
US Penny Stocks: 3 Picks With Market Caps Under $300M - Simply Wall St
ProKidney secures out-of-market buyer, $20.5 million price tag for Greensboro site - The Business Journals
ProKidney's high-profile Greensboro plant initiative ends with planned $20 million sale of property - Winston-Salem Journal
ProKidney (NASDAQ:PROK) Trading 8.7% HigherStill a Buy? - MarketBeat
Insiders In ProKidney Still Down 26% On US$54.7m Investment - Simply Wall St
Barclays PLC Has $281,000 Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
568,647 Shares in ProKidney Corp. (NASDAQ:PROK) Purchased by Hennion & Walsh Asset Management Inc. - MarketBeat
Jane Street Group LLC Has $78,000 Stock Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney Corp (PROK) Analyst Thoughts: How High Can It Go? - Stocks Register
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
ProKidney to Present at J.P. Morgan Healthcare Conference, Spotlight on CKD Cell Therapy - StockTitan
Geode Capital Management LLC Grows Stock Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
Geode Capital Management LLC Raises Stake in ProKidney Corp. (NASDAQ:PROK) - MarketBeat
Barclays PLC Purchases 124,667 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
One ProKidney Insider Raised Their Stake In The Previous Year - Yahoo Finance
Stories to Watch in 2025: Will ProKidney change its Winston-Salem plans after abandoning $458M Greensboro facility? - The Business Journals
Cortexyme (NASDAQ:CRTX) vs. ProKidney (NASDAQ:PROK) Head to Head Comparison - Defense World
State Street Corp Has $2.74 Million Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (NASDAQ:PROK) Shares Gap UpStill a Buy? - MarketBeat
TBJ's Top 24 of '24: ProKidney backs out of Guilford deal, invests in W-S facilities (No. 4) - Triad Business Journal
ProKidney (NASDAQ:PROK) Stock Price Down 2.5%Here's What Happened - MarketBeat
ProKidney (NASDAQ:PROK) Stock Price Up 6.2%Should You Buy? - MarketBeat
ProKidney (NASDAQ:PROK) Shares Down 4.8%Here's What Happened - MarketBeat
ProKidney Corp. (NASDAQ:PROK) Shares Bought by The Manufacturers Life Insurance Company - Defense World
Charles Schwab Investment Management Inc. Has $1.44 Million Holdings in ProKidney Corp. (NASDAQ:PROK) - MarketBeat
ProKidney (NASDAQ:PROK) Trading 5.9% HigherHere's What Happened - MarketBeat
Vigil Neuroscience (NASDAQ:VIGL) and ProKidney (NASDAQ:PROK) Head-To-Head Contrast - Defense World
JP Morgan Initiates Coverage of ProKidney (PROK) with Neutral Recommendation - MSN
ProKidney (NASDAQ:PROK) Trading 8.4% HigherWhat's Next? - MarketBeat
ProKidney (NASDAQ:PROK) Stock Price Up 5.4%Still a Buy? - MarketBeat
Suvretta Capital Management LLC Acquires 3,000,000 Shares of ProKidney Corp. (NASDAQ:PROK) - MarketBeat
ProKidney to Participate in Two Upcoming Conferences: - GlobeNewswire
ProKidney to Present at Evercore and Citi Healthcare Conferences in December | PROK Stock News - StockTitan
US Penny Stocks To Watch: 3 Picks With Market Caps Under $500M - Simply Wall St
The Best Laid Plans Of Mice And ProKidney… - The Rhino TImes
ProKidney purchases former Collins Aerospace facility, own HQ for $22.5M - The Business Journals
Future of development project promising hundreds of job now uncertain - MSN
ProKidney no longer coming to Greensboro, Chamber of Commerce confirms - MSN
ProKidney to buy two buildings in Winston-Salem. Announcement comes days after it listed Greensboro site for sale - Greensboro News & Record
ProKidney buys Winston-Salem land after passing on Greensboro deal - Business North Carolina
Prokidney Corp (PROK) 財務データ
収益
当期純利益
現金流量
EPS
5.49%
0.79%
大文字化:
|
ボリューム (24 時間):